Skip to content

Avanos Medical AVNS Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin50%-0.4pp50.5%-1.8pp52.3%-1.6pp53.8%-0.8pp54.6%-0.8pp
Operating margin-9.1%0.0pp-9.1%+59.8pp-69%-1.0pp-68%-11.4pp-56.6%+1.0pp
Net margin-10.4%0.0pp-10.4%+56.6pp-67%
EBITDA margin-3.6%0.0pp-3.6%+59.6pp-63.2%-1.4pp-61.8%-11.6pp-50.2%+0.8pp
Free cash flow margin1.6%-5.1pp6.7%-4.6pp11.3%-2.0pp13.3%-3.2pp16.5%+4.5pp
Returns
Return on equity-9.2%-0.1pp-9.1%+37.6pp-46.7%
Return on assets-6.9%-0.4pp-6.5%+27.9pp-34.4%
Return on invested capital-7.5%0.0pp-7.5%+36.7pp-44.2%-0.8pp-43.4%-8.7pp-34.7%+0.6pp
Efficiency
Asset turnover0.7×0.0×0.6×+0.1×0.5×0.0×0.5×0.0×0.5×0.0×
Inventory turnover2.6×+0.1×2.4×+0.3×2.1×+0.1×2.1×0.0×2.1×0.0×
Liquidity
Current ratio2.5×+0.3×2.2×-0.2×2.4×-0.3×2.6×+0.1×2.6×+0.2×
Quick ratio1.4×+0.1×1.3×-0.1×1.4×-0.2×1.6×0.0×1.6×0.0×
Cash ratio0.5×0.0×0.5×+0.1×0.5×-0.2×0.7×0.0×0.7×+0.1×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Interest coverage-9.1×-0.9×-8.2×+47.3×-55.5×-8.9×-46.6×-11.8×-34.8×-2.3×
Per Share
Book value per share$16.47-2.0%$16.81+0.2%$16.770.0%$16.77-6.5%$17.94-0.4%
Valuation
Market capitalization$1.17B+108%$521.28M-2.8%$536.41M-6.3%$572.5M-13.2%$659.23M-9.9%
Enterprise value$1.24B+105%$560.58M-6.5%$599.61M-3.2%$619.5M-11.9%$703.13M-11.5%
Price / sales1.6×+0.8×0.7×0.0×0.8×-0.1×0.8×-0.1×-0.1×
Price / book1.5×+0.8×0.7×0.0×0.7×0.0×0.7×0.0×0.8×-0.1×
EV / sales1.7×+0.9×0.8×-0.1×0.9×0.0×0.9×-0.1×-0.1×
Free cash flow yield1%-19.3pp9.1%-5.7pp14.7%-1.3pp16.1%-1.2pp17.3%+6.0pp
Earnings yield-6.4%+62.1pp-14%+73.4pp-87.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Avanos Medical's profit margins?
Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
Where do Avanos Medical's ratios come from?
Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.